5-fluoro-2,2'-cyclocytidine has been researched along with cytarabine in 4 studies
Studies (5-fluoro-2,2'-cyclocytidine) | Trials (5-fluoro-2,2'-cyclocytidine) | Recent Studies (post-2010) (5-fluoro-2,2'-cyclocytidine) | Studies (cytarabine) | Trials (cytarabine) | Recent Studies (post-2010) (cytarabine) |
---|---|---|---|---|---|
5 | 1 | 0 | 15,487 | 2,424 | 3,188 |
Protein | Taxonomy | 5-fluoro-2,2'-cyclocytidine (IC50) | cytarabine (IC50) |
---|---|---|---|
nuclear receptor coactivator 3 isoform a | Homo sapiens (human) | 7.533 | |
E3 ubiquitin-protein ligase Mdm2 | Homo sapiens (human) | 0.02 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brugarolas, A; Buesa, JM; Gracia Marco, M; Lacave, AJ; Valle Pereda, M | 1 |
Meyers, PA; Redner, A; Steinherz, PG; Tan, CT | 1 |
du Plessis, HE; Falkson, G; Falkson, HC; Meyer, TE | 1 |
Arlin, Z; Burchenal, JH; Clarkson, B; Comacho, E; Dowling, M; Drapkin, RL; Dufour, P; Gee, TS; Kempin, S; McKenzie, S; Mertelsmann, R; Oettgen, HF; Passe, S; Thaler, HT; To, L | 1 |
1 trial(s) available for 5-fluoro-2,2'-cyclocytidine and cytarabine
Article | Year |
---|---|
Treatment of acute nonlymphocytic leukemia in adults: response to 2,2-anhydro-1-B-D-arabinofuranosyl-5-fluorocytosine and thioguanine on the L-12 protocol.
Topics: Adolescent; Adult; Aged; Ancitabine; Antineoplastic Agents; Bacterial Vaccines; Cytarabine; Drug Therapy, Combination; Female; Humans; Leukemia; Leukemia, Myeloid, Acute; Male; Middle Aged; Prognosis; Pseudomonas aeruginosa; Random Allocation; Thioguanine | 1981 |
3 other study(ies) available for 5-fluoro-2,2'-cyclocytidine and cytarabine
Article | Year |
---|---|
Phase I and II clinical study of anhydro-ara-5-fluorocytosine (AAFC) and ICRF-159 combination in adenocarcinoma of digestive origin.
Topics: Adenocarcinoma; Adult; Aged; Ancitabine; Bone Marrow; Cytarabine; Digestive System Neoplasms; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Piperazines; Razoxane; Remission, Spontaneous | 1978 |
Diaziquone and 2,2'-anhydro-arabinosyl-5-fluorocytosine for the treatment of children with relapsed or refractory acute nonlymphoblastic leukemia.
Topics: Adolescent; Ancitabine; Antineoplastic Agents; Aziridines; Benzoquinones; Bone Marrow; Cell Survival; Child; Child, Preschool; Cytarabine; Drug Administration Schedule; Drug Evaluation; Female; Humans; Infant; Leukemia, Myeloid, Acute; Male | 1989 |
Anhydro-ara-5-fluorocytidine (AAFC) in gastrointestinal cancer. A phase II study.
Topics: Ancitabine; Antineoplastic Agents; Cytarabine; Drug Evaluation; Female; Gastrointestinal Neoplasms; Humans; Leukopenia; Male; Nausea; Vomiting | 1980 |